Condition

Digestive System Neoplasms clinical trials and research

• 12Clinical trials
• 1New in 30 days
• 18Countries

Newest Digestive System Neoplasms clinical trials

All recruiting trials (12)

• See if preoperative anxiety affects recovery after major digestive cancer surgery

  This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.

  Recruiting University Hospital, Rouen · Rouen · NCT07897942

• Benchmarking AI language models against tumor boards for oncology treatment decisions

  This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

• PF-08634404 plus chemotherapy for adults with metastatic colorectal cancer

  This trial will test whether adding a new drug called PF-08634404 to standard chemotherapy helps adults whose colorectal cancer has spread.

  Recruiting at 343 sites Phase 3 Pfizer · Chandler, Arizona and 371 other locations · NCT07222800

• Multimodal ablation with Tislelizumab, lenvatinib and TACE for unresectable primary liver cancer

  This trial will test whether combining multimodal ablation with Tislelizumab (a PD‑1 antibody), lenvatinib, and TACE helps people with unresectable primary liver cancer.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT06794073

• Personalized mRNA vaccine for advanced digestive system cancers

  This study is testing a new personalized mRNA vaccine for people with advanced digestive system cancers to see if it works better when used with standard treatment.

  Recruiting Phase 1 Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT06026800

• Personalized mRNA vaccine for patients with resected digestive system tumors

  This study is testing a personalized mRNA vaccine combined with standard treatment to see if it helps patients who have had surgery for advanced digestive system cancers feel better and improve their outcomes.

  Recruiting Phase 1 Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT06026774

• Personalized mRNA vaccine for advanced digestive system cancers

  This study is testing a personalized mRNA vaccine for people with advanced digestive system cancers to see if it is safe and effective after other treatments haven't worked.

  Recruiting Phase 1 Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT06019702

• Combining camrelizumab with chemoradiotherapy for advanced esophageal cancer

  This study is testing if adding a new immunotherapy drug called camrelizumab to standard chemotherapy and radiation can help people with advanced esophageal cancer feel better and improve their treatment results.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou · NCT05624099

• Combination of Anlotinib and TQB2450 for Esophageal Cancer Treatment

  This study is testing if combining two medications, Anlotinib and TQB2450, can help people with esophageal cancer stay cancer-free after surgery.

  Recruiting Phase 2 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT05252078

• Pooling clinical experiences of patients treated with Lutetium-177 in Spain

  This study looks at how well Lutetium-177 works and how safe it is for patients with certain types of tumors in Spain by collecting information from their medical records.

  Recruiting at 11 sites Sociedad Española de Medicina Nuclear e Imagen Molecular · Santiago de Compostela, A Coruña and 19 other locations · NCT04949282

• Second-line FOLFIRI +/- Bevacizumab vs Irinotecan +/- Bevacizumab in Metastatic Colorectal Cancer

  This trial tests whether a second-line FOLFIRI-based regimen with or without Bevacizumab is as good as Irinotecan-based therapy with or without Bevacizumab for patients with metastatic colorectal cancer.

  Recruiting Phase 3 Sun Yat-sen University · Guangzhou, Guangdong · NCT03303495

• EUS-guided radiofrequency ablation for small abdominal tumors

  This trial will try endoscopic ultrasound-guided radiofrequency ablation to treat small solid tumors (under 5 cm) in the liver, stomach, kidney, or adrenal glands in adults who are not candidates for surgery.

  Recruiting Chinese University of Hong Kong · Hong Kong · NCT03221335

Related topics

Quick answers

How many Digestive System Neoplasms clinical trials are recruiting right now?

12, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in China (8 trials), France (3 trials), Spain (2 trials), Hong Kong (1 trial), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 2: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →